新型膈肌移动度测量方法的验证研究:相控阵探头在肝肾/脾肾切面评估膈肌移动度
研究纳入12名健康受试者,由4名操作者(2名经验丰富重症医师、2名经验不足呼吸治疗师)分别用传统肝/脾切面凸阵探头M型与新型肝肾/脾肾切面相控阵探头解剖M型测量膈肌移动度。肝肾/脾肾切面获取率100%(48/48),肝切面91.7%(44/48),脾切面66.7%(32/48),左膈评估中脾肾切面获取率显著高于脾切面(P<0.01)。肝肾切面与脾肾切面测值无显著差异(1.64±0.10 cm vs 1.55±0.14 cm,P>0.05),且均显著高于传统肝/脾切面(肝肾vs肝1.64±0.10 vs 1.44±0.09 cm,脾肾vs脾1.55±0.14 vs 1.09±0.14 cm,均P<0.01)。肝肾与脾肾切面间、肝与肝肾切面间一致性良好(一致性界限均<40%),作者认为新方法准确、可重复性高,可作为传统方法的可行替代。
要点
- 肝肾/脾肾切面膈肌移动度获取率100%(48/48),显著高于脾切面66.7%(32/48),左膈评估中脾肾切面获取率显著高于脾切面(P<0.01)。
- 肝肾切面测值1.64±0.10 cm与脾肾切面1.55±0.14 cm无显著差异(P>0.05),均显著高于传统肝切面1.44±0.09 cm和脾切面1.09±0.14 cm(均P<0.01)。
- 肝肾与脾肾切面间、肝与肝肾切面间一致性良好(一致性界限均<40%),脾切面与其他三切面不相关且一致性界限均>40%。
- 4名操作者在四个切面测值组间比较均无统计学显著差异(均P>0.05),且所有切面一致性界限均<40%。
- 作者认为经肝肾/脾肾切面测量膈肌移动度准确、可重复性高、获取率高,可作为传统肝/脾切面方法的可行替代。
适用人群与场景
- 12名健康受试者,用于验证新型膈肌移动度测量方法的准确性与可重复性。
诊断标准与关键阈值
- 临床可接受的一致性定义为无固定偏倚和比例偏倚,且两次测量差值的2倍标准差小于平均测量值的40%。
- 百分比一致性界限=测量间差值的2倍标准差/平均测量值×100%。
处置流程与药物剂量
- 传统方法:使用1.5-6.0 MHz凸阵探头M型,取样线垂直于膈肌最大移动点,在受试者正常呼吸时于肝/脾切面测定膈肌移动度。
- 新方法:使用1.6-4.5 MHz相控阵探头,沿腋中线观察膈肌头尾方向运动,采用解剖M型,取样线垂直于肾中点水平的膈肌,在正常呼吸时测量肝肾/脾肾切面膈肌移动度。
- 肝切面和肝肾切面用于评估右侧膈肌,脾切面和脾肾切面用于评估左侧膈肌。
研究设计与关键结果
- 研究类型为方法学验证研究,纳入12名健康受试者,由4名操作者(2名经验丰富重症医师,膈肌超声操作>50例;2名经验不足呼吸治疗师,操作<10例,研究前接受2小时理论与操作培训)分别用传统肝/脾切面与新型肝肾/脾肾切面测量膈肌移动度。
- 肝肾/脾肾切面膈肌移动度获取率100%(48/48),肝切面91.7%(44/48),脾切面66.7%(32/48);左膈评估中脾肾切面获取率显著高于脾切面(P<0.01)。
- 肝肾切面与脾肾切面测值无显著差异(cm:1.64±0.10 vs 1.55±0.14,P>0.05),且均显著高于传统肝/脾切面(cm:肝肾vs肝1.64±0.10 vs 1.44±0.09,脾肾vs脾1.55±0.14 vs 1.09±0.14,均P<0.01)。
- 肝肾与脾肾切面间、肝与肝肾切面间、肝与脾肾切面间相关性良好(r值分别为0.62、0.59、0.42,均P<0.01)。
- 肝肾与脾肾切面间、肝与肝肾切面间一致性良好(一致性界限均<40%);脾切面测值与其他三切面不相关,且无一致性(一致性界限均>40%)。
- 4名操作者在肝、脾、肝肾、脾肾切面测值组间比较均无统计学显著差异(cm:肝切面1.49±0.34、1.44±0.37、1.43±0.30、1.40±0.27;脾切面1.10±0.36、1.05±0.18、1.09±0.22、1.06±0.26;肝肾切面1.67±0.43、1.57±0.34、1.63±0.32、1.66±0.36;脾肾切面1.45±0.33、1.48±0.34、1.50±0.24、1.65±0.26;均P>0.05)。
- 按临床可接受的一致性界限范围,4名操作者在四个切面的测值均显示良好一致性(所有百分比一致性界限均<40%)。
证据类型、等级与局限
- 证据类型:方法学验证研究(健康受试者)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为经肝肾/脾肾切面测量膈肌移动度准确、可重复性高、获取率高,可作为传统肝/脾切面方法的可行替代。
- 经验不足操作者(呼吸治疗师,操作<10例)经2小时理论与操作培训后,四切面测值与经验丰富者无统计学显著差异(均P>0.05),提示该测量方法学习曲线可能较短。
- 脾切面测值与其他三切面不相关且一致性界限均>40%,左膈评估中脾肾切面获取率显著高于脾切面(P<0.01)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the accuracy and reproducibility of diaphragmatic excursion (DE) measurements through hepato-renal/spleno-renal section as a novel method for assessing diaphragmatic function.
METHODS: Twelve healthy participants were recruited. Each participant underwent DE measurements performed by four operators with varying levels of experience using traditional methods (liver/spleen section) and novel methods (hepato-renal/spleno-renal section), respectively. Among them, two experienced operators were critical care clinicians, and diaphragmatic ultrasound was performed in more than 50 cases. The other two inexperienced operators were respiratory therapists, with less than 10 cases of diaphragmatic ultrasound operations, who received a 2-hour theoretical and operational training before the study. Operators initially used the conventional method with a 1.5-6.0 MHz convex probe in M-mode, placing the sampling line perpendicular to the diaphragm at the point of maximum excursion, and the liver/spleen section DE was determined during normal breathing of participant. Then, they used the novel method with a 1.6-4.5 MHz phased array probe to observe diaphragmatic movement cranio-caudally along the mid-axillary line, employing anatomic M-mode with the sampling line placed perpendicular to the diaphragm at the level of the renal midpoint, and the DE of the hepato-renal/spleno-renal section was measured during normal breathing. The liver and hepato-renal sections were used to assess the right diaphragm, and spleen and spleno-renal sections were used to assess the left diaphragm. Correlation analysis of DE measurements from different sections was conducted using the Deming method, while consistency was assessed using the Bland-Altman method. The consistency of clinical acceptability was defined as the absence of fixed and proportional bias, with a difference of two standard deviations less than 40% of the mean measurement value. Percentage consistency limit = two standard deviations of the differences between measurements/mean measurement value×100%.
RESULTS: Four operators performed image scans of DE in all four sections for each of the twelve subjects, with a high DE acquisition rate of 100% (48/48) for hepato-renal and spleno-renal sections, followed by the liver section [91.7% (44/48)] and the spleen section [66.7% (32/48)], particularly for the left diaphragm assessment, where the DE acquisition rate of spleno-renal section was significantly higher than that of traditional spleen section (P < 0.01). The overall measurement results showed that no significant difference was found in DE determined via the hepato-renal and spleno-renal sections using the novel method (cm: 1.64±0.10 vs. 1.55±0.14, P > 0.05), and they were significantly higher than those determined via the conventional liver and spleen sections (cm: hepato-renal section vs. liver section was 1.64±0.10 vs. 1.44±0.09, spleno-renal section vs. spleen section was 1.55±0.14 vs. 1.09±0.14, both P < 0.01). Correlation analysis revealed good correlations of DE between hepato-renal section and spleno-renal section, between liver section and hepato-renal section, between liver section and spleno-renal section (r values were 0.62, 0.59, and 0.42, all P < 0.01). Consistency analysis showed that the consistency in DE between hepato-renal section and spleno-renal section, as well as between liver section and hepato-renal section was good (both % consistency limits < 40%). However, the DE measured in the spleen section were not correlated with the other three sections, and there was no inconsistency (all % consistency limits > 40%). There was no statistically significant difference in DE measured by the four operators in the liver, spleen, hepato-renal, and spleno-renal sections (cm: 1.49±0.34, 1.44±0.37, 1.43±0.30, and 1.40±0.27 in liver section; 1.10±0.36, 1.05±0.18, 1.09±0.22, and 1.06±0.26 in spleen section; 1.67±0.43, 1.57±0.34, 1.63±0.32, and 1.66±0.36 in hepato-renal section; 1.45±0.33, 1.48±0.34, 1.50±0.24, and 1.65±0.26 in spleno-renal section; all P > 0.05). According to the clinically acceptable range of consistency limits, the DE measured by the four operators in all four sections showed good consistency (all % consistency limits < 40%).
CONCLUSIONS: The novel method of measuring DE through hepato-renal/spleno-renal sections is accurate, highly reproducible, and has a high acquisition rate, serving as a viable alternative to the conventional method involving the liver/spleen section.
参考来源
- Ma J, Zhai S, Sun X, et al. [Validation study of a novel diaphragmatic excursion measurement method: evaluation of diaphragmatic excursion by phased-array probe in hepato-renal/spleno-renal section]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39223890. doi:10.3760/cma.j.cn121430-20240207-00118
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。